---
title: "Propoxyphene - Complete Profile"
substance: "Propoxyphene"
chemical_name: "(1S,2R)-1-benzyl-3-(dimethylamino)-2-methyl-1-phenylpropyl propanoate"
category: "Depressant"
legal_status: "Withdrawn from market (US), Discontinued globally"
description: "A withdrawn synthetic opioid analgesic - removed from global markets due to fatal cardiac arrhythmias"
permalink: "/dyos-domain/substances/propoxyphene/"
---

<div class="substance-profile-header">
  <div class="container">
    <nav class="breadcrumb">
      <a href="/dyos-domain/">Dyo's Domain</a> ‚Ü≠ <a href="/dyos-domain/depressants/">Depressants</a> ‚Ü≠ <span>Propoxyphene</span>
    </nav>
    
    <div class="substance-hero">
      <div class="substance-info">
        <h1>üåô Propoxyphene</h1>
        <h2 class="chemical-name">(1S,2R)-1-benzyl-3-(dimethylamino)-2-methyl-1-phenylpropyl propanoate</h2>
        
        <!-- Add to Profile Button -->
        <button id="add-to-profile-btn" class="add-to-profile-btn not-in-profile" 
                data-substance="Propoxyphene" 
                data-category="Depressants" 
                data-chemical="(1S,2R)-1-benzyl-3-(dimethylamino)-2-methyl-1-phenylpropyl propanoate">
          + Add to My Profile
        </button>
        
        <div class="alternative-names">
          <h3>Alternative Names & Slang</h3>
          <div class="names-grid">
            <span class="name-tag brand">Darvon</span>
            <span class="name-tag brand">Darvocet</span>
            <span class="name-tag brand">Distalgesic</span>
            <span class="name-tag brand">Co-proxamol</span>
            <span class="name-tag pharmaceutical">Propoxyphene HCl</span>
            <span class="name-tag pharmaceutical">Propoxyphene Napsylate</span>
            <span class="name-tag discontinued">Doloxene</span>
            <span class="name-tag discontinued">Dextropropoxyphene</span>
            <span class="name-tag street">Pinks</span>
            <span class="name-tag street">Pink Ladies</span>
            <span class="name-tag medical">DXP</span>
            <span class="name-tag historical">Lib 10</span>
          </div>
        </div>
        
        <div class="substance-meta-large">
          <span class="category depressant">Withdrawn Opioid</span>
          <span class="legal-status withdrawn">WITHDRAWN</span>
          <span class="duration medium">4-6 hours</span>
        </div>
      </div>
      
      <div class="substance-visual">
        <div class="substance-image">
          <img src="{{ '/assets/substances/propoxyphene.jpg' | url }}" alt="Propoxyphene capsules and tablets" class="substance-photo">
        </div>
        <div class="molecule-structure">
          <div class="structure-placeholder">
            <p>C‚ÇÇ‚ÇÇH‚ÇÇ‚ÇâNO‚ÇÇ</p>
            <small>Molecular Structure</small>
          </div>
        </div>
      </div>
    </div>
  </div>
</div>

<div class="container">
  
  <div class="profile-grid">
    
    <div class="profile-section identification">
      <h3>üîç Physical Identification</h3>
      <div class="identification-info">
        <div class="pure-form">
          <h4>Pure Propoxyphene (HCl salt)</h4>
          <ul>
            <li><strong>Appearance:</strong> White, crystalline powder</li>
            <li><strong>Odor:</strong> Odorless or slight characteristic odor</li>
            <li><strong>Taste:</strong> Bitter taste</li>
            <li><strong>Solubility:</strong> Freely soluble in water and alcohol</li>
            <li><strong>Melting point:</strong> 163-168.5¬∞C (HCl salt)</li>
          </ul>
        </div>
        
        <div class="street-forms">
          <h4>Historical Medical Forms</h4>
          <ul>
            <li><strong>Pink capsules:</strong> 65mg propoxyphene HCl (Darvon)</li>
            <li><strong>Pink/gray capsules:</strong> 100mg propoxyphene napsylate</li>
            <li><strong>Combination tablets:</strong> Propoxyphene + acetaminophen (Darvocet)</li>
            <li><strong>Co-proxamol:</strong> Propoxyphene + paracetamol (UK formulation)</li>
          </ul>
        </div>
        
        <div class="adulterants-warning">
          <h4>‚ö†Ô∏è Discontinuation Notice</h4>
          <p><strong>Market withdrawal:</strong> Removed from global markets 2009-2010 due to cardiac toxicity</p>
          <p><strong>Current availability:</strong> No legitimate pharmaceutical sources remain</p>
          <p><strong>Street presence:</strong> Extremely rare, mostly expired diverted stock</p>
          <p><strong>Safety concerns:</strong> Any remaining supplies likely degraded and dangerous</p>
        </div>
      </div>
    </div>
    
    <div class="profile-section dosage">
      <h3>üíä Historical Dosage Guidelines</h3>
      <div class="dosage-chart">
        <div class="dose-range threshold">
          <span class="range-label">Threshold</span>
          <span class="dose-amount">30-50mg</span>
          <div class="dose-bar"></div>
        </div>
        <div class="dose-range light">
          <span class="range-label">Light</span>
          <span class="dose-amount">50-65mg</span>
          <div class="dose-bar"></div>
        </div>
        <div class="dose-range common">
          <span class="range-label">Common (Medical)</span>
          <span class="dose-amount">65-130mg</span>
          <div class="dose-bar"></div>
        </div>
        <div class="dose-range strong">
          <span class="range-label">Strong</span>
          <span class="dose-amount">130-200mg</span>
          <div class="dose-bar"></div>
        </div>
        <div class="dose-range heavy">
          <span class="range-label">Dangerous</span>
          <span class="dose-amount">200mg+</span>
          <div class="dose-bar"></div>
        </div>
      </div>
      
      <div class="dosage-details">
        <h4>Historical Medical Dosing</h4>
        <ul>
          <li><strong>Standard dose:</strong> 65mg every 4 hours as needed for pain</li>
          <li><strong>Maximum daily:</strong> 390mg (6 doses) - often exceeded</li>
          <li><strong>Elderly patients:</strong> Reduced doses recommended due to toxicity</li>
          <li><strong>Combination products:</strong> Limited by acetaminophen toxicity</li>
          <li><strong>Tolerance:</strong> Develops rapidly, leading to dose escalation</li>
          <li><strong>Withdrawal:</strong> Occurs within 12-24 hours of cessation</li>
        </ul>
      </div>
      
      <p class="dosage-note"><strong>Critical Warning:</strong> Propoxyphene was withdrawn globally due to fatal cardiac arrhythmias. No safe dose exists for recreational use.</p>
    </div>

    <div class="profile-section effects">
      <h3>‚ú® Effects Profile</h3>
      
      <div class="effects-timeline">
        <h4>Timeline (Oral)</h4>
        <div class="timeline-item">
          <span class="time">T+0:30-1:00</span>
          <span class="effect">Onset - mild analgesia, slight euphoria</span>
        </div>
        <div class="timeline-item">
          <span class="time">T+1:00-3:00</span>
          <span class="effect">Peak - maximum analgesia, mood elevation</span>
        </div>
        <div class="timeline-item">
          <span class="time">T+3:00-6:00</span>
          <span class="effect">Plateau - sustained but weak effects</span>
        </div>
        <div class="timeline-item">
          <span class="time">T+6:00-12:00</span>
          <span class="effect">Comedown - gradual return to baseline</span>
        </div>
      </div>

      <div class="effects-categories">
        <div class="effect-category positive">
          <h4>‚úÖ Therapeutic Effects (Historical)</h4>
          <ul>
            <li>Mild to moderate analgesia</li>
            <li>Slight euphoria and mood lift</li>
            <li>Anxiety reduction</li>
            <li>Mild sedation</li>
            <li>Cough suppression</li>
            <li>Antidiarrheal effects</li>
          </ul>
        </div>
        
        <div class="effect-category negative">
          <h4>‚ùå Adverse Effects</h4>
          <ul>
            <li>Cardiac arrhythmias (potentially fatal)</li>
            <li>QT interval prolongation</li>
            <li>Nausea and vomiting</li>
            <li>Dizziness and confusion</li>
            <li>Constipation</li>
            <li>Respiratory depression (mild)</li>
            <li>Physical dependence and withdrawal</li>
          </ul>
        </div>
      </div>
    </div>

    <div class="profile-section pharmacology">
      <h3>üß† Pharmacology & Neuroscience</h3>
      <div class="pharma-details">
        <h4>Primary Mechanism of Action</h4>
        <p>Propoxyphene is a synthetic opioid that acts primarily as a weak Œº-opioid receptor agonist. Unlike other opioids, it also has significant activity at sodium channels, contributing to its cardiotoxic effects. The drug also inhibits norepinephrine and serotonin reuptake, giving it mild antidepressant-like properties.</p>
        
        <h4>Detailed Receptor Pharmacology</h4>
        <div class="receptor-table">
          <div class="receptor-row">
            <span class="receptor">Œº-Opioid Receptor</span>
            <span class="affinity">Low-Moderate</span>
            <span class="effect">Weak analgesic and euphoric effects</span>
          </div>
          <div class="receptor-row">
            <span class="receptor">Na+ Channels</span>
            <span class="affinity">Moderate</span>
            <span class="effect">Cardiac sodium channel blockade (dangerous)</span>
          </div>
          <div class="receptor-row">
            <span class="receptor">SERT (Serotonin)</span>
            <span class="affinity">Low</span>
            <span class="effect">Weak serotonin reuptake inhibition</span>
          </div>
          <div class="receptor-row">
            <span class="receptor">NET (Norepinephrine)</span>
            <span class="affinity">Low</span>
            <span class="effect">Weak norepinephrine reuptake inhibition</span>
          </div>
          <div class="receptor-row">
            <span class="receptor">hERG K+ Channels</span>
            <span class="affinity">Moderate</span>
            <span class="effect">QT prolongation (arrhythmia risk)</span>
          </div>
        </div>

        <h4>Metabolism & Pharmacokinetics</h4>
        <div class="metabolism-details">
          <p><strong>Primary Pathway:</strong> N-demethylation by CYP2D6 ‚Üí Norpropoxyphene (active, more toxic)</p>
          <p><strong>Secondary Pathway:</strong> Hydrolysis and glucuronidation</p>
          <p><strong>Half-life:</strong> 6-12 hours (parent), 30-36 hours (norpropoxyphene)</p>
          <p><strong>Bioavailability:</strong> ~65% oral (variable)</p>
          <p><strong>Peak plasma:</strong> 2-3 hours after oral dose</p>
          <p><strong>Elimination:</strong> Primarily renal, norpropoxyphene accumulates</p>
        </div>

        <h4>Cardiotoxicity Mechanisms</h4>
        <div class="neurotoxicity-info">
          <p><strong>Sodium channel blockade:</strong> Direct cardiac sodium channel inhibition disrupts electrical conduction</p>
          <p><strong>QT prolongation:</strong> hERG potassium channel blockade prolongs cardiac repolarization</p>
          <p><strong>Norpropoxyphene accumulation:</strong> Active metabolite is more cardiotoxic than parent drug</p>
          <p><strong>Cumulative toxicity:</strong> Long half-life of metabolite leads to dangerous accumulation</p>
        </div>

        <h4>Unique Pharmacological Properties</h4>
        <ul>
          <li><strong>Weak opioid activity:</strong> Poor analgesic efficacy compared to codeine or tramadol</li>
          <li><strong>Monoamine reuptake inhibition:</strong> Mild antidepressant-like effects</li>
          <li><strong>Local anesthetic:</strong> Sodium channel blockade provides membrane-stabilizing effects</li>
          <li><strong>Long-acting metabolite:</strong> Norpropoxyphene has 3-5x longer half-life</li>
          <li><strong>Poor risk/benefit ratio:</strong> Minimal analgesic benefit with significant cardiac risk</li>
        </ul>
      </div>
    </div>

    <div class="profile-section safety">
      <h3>‚ö†Ô∏è Safety & Harm Reduction</h3>
      
      <div class="safety-grid">
        <div class="safety-item critical">
          <h4>üö® Critical Warnings</h4>
          <ul>
            <li><strong>Cardiac arrhythmias:</strong> Can cause sudden death even at therapeutic doses</li>
            <li><strong>Market withdrawal:</strong> Removed globally due to unacceptable risk profile</li>
            <li><strong>Norpropoxyphene toxicity:</strong> Active metabolite accumulates with repeated dosing</li>
            <li><strong>QT prolongation:</strong> Dangerous interaction with other QT-prolonging drugs</li>
            <li><strong>No legitimate supply:</strong> Any available supplies are illicit or expired</li>
          </ul>
        </div>
        
        <div class="safety-item precautions">
          <h4>üõ°Ô∏è Historical Harm Reduction (Educational)</h4>
          <ul>
            <li><strong>Avoid completely:</strong> No safe way to use due to cardiac toxicity</li>
            <li><strong>Cardiac monitoring:</strong> ECG monitoring required for any exposure</li>
            <li><strong>Drug interactions:</strong> Dangerous with other QT-prolonging medications</li>
            <li><strong>Overdose risk:</strong> Narrow therapeutic window, easy to overdose</li>
            <li><strong>Safer alternatives:</strong> Modern opioids have better safety profiles</li>
            <li><strong>Medical supervision:</strong> Should only be handled by medical professionals</li>
          </ul>
        </div>
      </div>

      <div class="contraindications">
        <h4>üö´ Absolute Contraindications</h4>
        <p><strong>Never use if you have:</strong> Any heart condition, arrhythmias, QT prolongation, are taking other QT-prolonging drugs, have kidney disease, or are elderly. Propoxyphene is contraindicated in ALL populations.</p>
      </div>
    </div>

    <div class="profile-section interactions">
      <h3>‚öóÔ∏é Drug Interactions</h3>
      
      <div class="interaction-levels">
        <div class="interaction dangerous">
          <h4>üíÄ Deadly Combinations</h4>
          <ul>
            <li><strong>QT-prolonging drugs:</strong> Antiarrhythmics, antipsychotics, antibiotics</li>
            <li><strong>CNS depressants:</strong> Alcohol, benzodiazepines, barbiturates</li>
            <li><strong>CYP2D6 inhibitors:</strong> Increase norpropoxyphene accumulation</li>
            <li><strong>Other opioids:</strong> Compounded respiratory depression</li>
          </ul>
        </div>
        
        <div class="interaction risky">
          <h4>üî¥ High Risk Combinations</h4>
          <ul>
            <li><strong>Antidepressants:</strong> SSRIs, tricyclics - cardiac conduction effects</li>
            <li><strong>Beta-blockers:</strong> Masking of arrhythmia symptoms</li>
            <li><strong>Calcium channel blockers:</strong> Additional cardiac depression</li>
            <li><strong>Diuretics:</strong> Electrolyte imbalances increase arrhythmia risk</li>
          </ul>
        </div>
        
        <div class="interaction caution">
          <h4>‚ö†Ô∏è Use With Extreme Caution</h4>
          <ul>
            <li><strong>Any cardiac medications:</strong> Unpredictable interactions</li>
            <li><strong>Sedating antihistamines:</strong> Increased CNS depression</li>
            <li><strong>Muscle relaxants:</strong> Enhanced sedation and respiratory risk</li>
          </ul>
        </div>
      </div>
    </div>

    <div class="profile-section legal">
      <h3>‚öñÔ∏é Legal Status</h3>
      <div class="legal-info">
        <div class="legal-jurisdictions">
          <h4>Global Withdrawal Status</h4>
          <ul>
            <li><strong>United States:</strong> Market withdrawal November 2010 (FDA)</li>
            <li><strong>European Union:</strong> Withdrawn 2009 (EMA recommendation)</li>
            <li><strong>United Kingdom:</strong> Co-proxamol withdrawn 2007</li>
            <li><strong>Australia:</strong> Withdrawn 2012</li>
            <li><strong>Canada:</strong> Voluntary withdrawal by manufacturers</li>
            <li><strong>Global status:</strong> No longer approved anywhere</li>
          </ul>
        </div>
        
        <div class="therapeutic-status">
          <h4>Current Medical Status</h4>
          <p><strong>Discontinued globally:</strong> No legitimate medical uses remain. Withdrawn due to unacceptable risk-benefit ratio after decades of clinical use revealed fatal cardiac toxicity that outweighed modest analgesic benefits.</p>
        </div>
      </div>
    </div>

    <div class="profile-section history">
      <h3>üìö History & Culture</h3>
      
      <div class="history-timeline">
        <div class="history-event">
          <span class="year">1953</span>
          <span class="event">Developed by Eli Lilly as a cough suppressant and analgesic</span>
        </div>
        <div class="history-event">
          <span class="year">1957</span>
          <span class="event">FDA approval for Darvon (propoxyphene HCl) in the United States</span>
        </div>
        <div class="history-event">
          <span class="year">1960s-70s</span>
          <span class="event">Peak popularity as "safer alternative" to stronger opioids</span>
        </div>
        <div class="history-event">
          <span class="year">1978</span>
          <span class="event">First reports of cardiac toxicity and sudden deaths emerge</span>
        </div>
        <div class="history-event">
          <span class="year">1980s-90s</span>
          <span class="event">Growing concerns about efficacy and safety, suicide attempts</span>
        </div>
        <div class="history-event">
          <span class="year">2007-2010</span>
          <span class="event">Global market withdrawals due to cardiac arrhythmia risk</span>
        </div>
        <div class="history-event">
          <span class="year">Present</span>
          <span class="event">Serves as cautionary tale in pharmaceutical safety</span>
        </div>
      </div>

      <div class="cultural-impact">
        <h4>Medical Legacy</h4>
        <p>Propoxyphene represents a major pharmaceutical safety lesson - a drug that appeared safe and effective for decades before post-market surveillance revealed its deadly cardiac effects. Its withdrawal highlighted the importance of long-term safety monitoring and led to stricter regulatory oversight of cardiac safety in drug development.</p>
      </div>
    </div>

    <div class="profile-section research">
      <h3>üî¨ Current Research</h3>
      
      <div class="research-areas">
        <div class="research-item">
          <h4>Cardiotoxicity Studies</h4>
          <p>Ongoing research into propoxyphene's cardiac mechanisms to prevent similar issues in future drug development.</p>
        </div>
        
        <div class="research-item">
          <h4>Pharmacovigilance</h4>
          <p>Case studies in post-market surveillance and how subtle cardiac toxicity can be missed for decades.</p>
        </div>
        
        <div class="research-item">
          <h4>Withdrawal Impact</h4>
          <p>Studies on healthcare outcomes after propoxyphene withdrawal and opioid prescribing patterns.</p>
        </div>
        
        <div class="research-item">
          <h4>Regulatory Science</h4>
          <p>Analysis of regulatory decision-making and the propoxyphene withdrawal as a landmark case.</p>
        </div>
      </div>
    </div>

  </div>

  <div class="substance-resources">
    <h3>üìñ Additional Resources</h3>
    <div class="resources-grid">
      <div class="resource-item">
        <h4>Regulatory Information</h4>
        <ul>
          <li><a href="https://www.fda.gov/drugs/drug-safety-and-availability">FDA Drug Safety Communications</a></li>
          <li><a href="https://www.ema.europa.eu/en">European Medicines Agency</a></li>
          <li><a href="https://pubmed.ncbi.nlm.nih.gov/">PubMed - Propoxyphene cardiac toxicity</a></li>
        </ul>
      </div>
      
      <div class="resource-item">
        <h4>Medical Literature</h4>
        <ul>
          <li><a href="https://www.ncbi.nlm.nih.gov/books/">NCBI Bookshelf - Drug Safety</a></li>
          <li><a href="https://www.erowid.org/chemicals/propoxyphene/">Erowid - Propoxyphene Vault</a></li>
          <li><a href="https://psychonautwiki.org/wiki/Propoxyphene">PsychonautWiki - Propoxyphene</a></li>
        </ul>
      </div>
      
      <div class="resource-item">
        <h4>Support & Treatment</h4>
        <ul>
          <li><a href="https://www.samhsa.gov/">SAMHSA National Helpline</a></li>
          <li><a href="https://www.na.org/">Narcotics Anonymous</a></li>
          <li><a href="https://www.smart-recovery.org/">SMART Recovery</a></li>
        </ul>
      </div>
    </div>
  </div>

</div>